Autologous Chondrocyte Implantation versus Debridement for Treatment of Full-Thickness Chondral Defects of the Knee

  • Freddie H. Fu
    University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania
  • David Zurakowski
    Children's Hospital, Harvard Medical School, Boston, Massachusetts
  • Jon E. Browne
    Orthopaedic Sports Medicine Fellowship Program, University of Missouri-Kansas City, Kansas City, Missouri
  • Bert Mandelbaum
    Santa Monica Orthopaedic and Sports Medicine Research Foundation, Santa Monica, California
  • Christoph Erggelet
    Department of Orthopaedic Surgery, Albert-Ludwigs University, Freiburg, Germany
  • J. Bruce Moseley
    Baylor Sports Medicine Institute, Baylor College of Medicine, Houston, Texas
  • Allen F. Anderson
    Sports Medicine Fellowship, Tennessee Sports Alliance/The Lipscomb Clinic, Nashville, Tennessee
  • Lyle J. Micheli
    Division of Sports Medicine, Department of Orthopaedic Surgery, Children,s Hospital, Harvard Medical School, Boston, Massachusetts

書誌事項

タイトル別名
  • An Observational Cohort Study with 3-Year Follow-up
公開日
2005-11
権利情報
  • https://journals.sagepub.com/page/policies/text-and-data-mining-license
DOI
  • 10.1177/0363546505275148
公開者
SAGE Publications

この論文をさがす

説明

<jats:sec><jats:title>Background</jats:title><jats:p> Studies that compare the effectiveness of different cartilage repair treatments are needed to update treatment algorithms. </jats:p></jats:sec><jats:sec><jats:title>Hypothesis</jats:title><jats:p> Autologous chondrocyte implantation provides greater improvement in overall condition score than does debridement at a minimum of 3 years’ follow-up. </jats:p></jats:sec><jats:sec><jats:title>Study Design</jats:title><jats:p> Cohort study; Level of evidence, 3. </jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p> Cohorts for debridement and autologous chondrocyte implantation each included 58 Cartilage Repair Registry patients who met study criteria. A retrospective analysis was performed on prospectively collected baseline and follow-up data. </jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p> Patients in the autologous chondrocyte implantation and debridement groups had similar demographics and chondral lesions at baseline. However, more autologous chondrocyte implantation patients failed a previous debridement or marrow stimulation procedure than did debridement patients. Follow-up outcome assessments were completed by 54 autologous chondrocyte implantation patients and 42 debridement patients. Eighty-one percent of the autologous chondrocyte implantation patients and 60% of the debridement patients reported median improvements of 5 points and 2 points, respectively, in the overall condition score. Autologous chondrocyte implantation patients also reported greater improvements in the median pain and swelling scores than did debridement patients. The treatment failure rate was the same for both autologous chondrocyte implantation and debridement patients. Eighteen autologous chondrocyte implantation patients and 1 debridement patient had at least 1 subsequent operation. </jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p> Although patients treated with debridement for symptomatic, large, focal, chondral defects of the distal femur had some functional improvement at follow-up, patients who received autologous chondrocyte implantations obtained higher levels of knee function and had greater relief from pain and swelling at 3 years. </jats:p></jats:sec>

収録刊行物

被引用文献 (1)*注記

もっと見る

問題の指摘

ページトップへ